Home/Filings/4/0001610717-25-000213
4//SEC Filing

Mohindru Mani 4

Accession 0001610717-25-000213

CIK 0001501989other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:18 PM ET

Size

5.3 KB

Accession

0001610717-25-000213

Insider Transaction Report

Form 4
Period: 2025-06-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-11+38,00038,000 total
    Exercise: $2.82Exp: 2035-06-10Common Stock (38,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001664708

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:18 PM ET
Size
5.3 KB